CIBC Bancorp USA »

Arbutus Biopharma shares owned by CIBC Bancorp USA

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by CIBC Bancorp USA from 13F filings

Historical chart of CIBC Bancorp USA investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by CIBC Bancorp USA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by CIBC Bancorp USA

Quarter filed Position value Share count Share price at filing
2025-09-30 $73k 16k 4.54

More positions owned by CIBC Bancorp USA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Ishares Tr U.s. Real Es Etf (IYR)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Linde SHS (LIN)
Cognizant Technology Solutio Cl A (CTSH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for CIBC Bancorp USA

Top funds holding Arbutus Biopharma

Whitefort Capital Management
BlackRock
Two Seas Capital
Vanguard Group
State Street Corporation
ADAR1 Capital Management
Adage Capital Partners GP
Geode Capital Management
Woodline Partners
BlackBarn Capital Partners
Rubric Capital Management
Charles Schwab Investment Management
Advisor Group Holdings
Northern Trust
Stempoint Capital

View all funds holding Arbutus Biopharma